Biohacking entrepreneur Bryan Johnson broadcasted a five-hour psilocybin session via livestream this week to investigate how psychedelics can trigger “longevity escape velocity,” a move that Silicon Valley’s elite are hailing as a necessary defiance of traditional regulatory hurdles. By documenting his measured hallucinogen intake, Johnson aims to bypass the perceived stagnation of modern science and provide a blueprint for reversing biological aging by 2039.
Challenging the Regulatory Status Quo
Naval Ravikant, the prominent investor and founder of AngelList, characterized Johnson as a “one-man FDA,” expressing frustration that scientific progress remains tethered to the cautious pace of regulators and bioethicists. This perspective mirrors the techno-optimist manifesto published by Marc Andreessen, which argues that “social responsibility” and ethics frequently serve as obstacles to radical innovation.
Ravikant praised Johnson’s autonomous approach, stating that the biohacker has decided to “blaze the trail” himself. “I hope he survives for a long time and then gives us the cheat codes,” Ravikant remarked during the stream, suggesting that the tech community desires thousands of individuals following Johnson’s experimental lead.
A Modern Evolution of the Psychedelic Movement
While Johnson remained isolated under an eye mask and a weighted blanket, journalist Ashlee Vance noted that the livestream format added a layer of performative burden to the experience. Despite the spectacle, Johnson’s focus on psilocybin as a tool for life extension is rooted in emerging science. Researchers are currently conducting peer-reviewed studies on the therapeutic potential of hallucinogens, though Johnson’s public methodology is far more aggressive.
The experiment draws parallels to the 1960s, when Harvard psychologist Timothy Leary championed psychedelics for “SMI²LE”—an acronym for space migration, intelligence increase, and life extension. While Leary’s movement was intertwined with the counterculture of the Grateful Dead and Ken Kesey, Johnson has rebranded the practice for the corporate era. Where Leary inspired the lyrics of John Lennon, Johnson inspires the investment portfolios of Silicon Valley.
The Technical Pursuit of Biological Stasis
The core of Johnson’s mission is “longevity escape velocity,” a theoretical point where biological aging is completely neutralized. “Time passes, but you stay the same age biologically,” Johnson explained, calling it the most significant potential achievement for the human race. His collaborator, Tolo, was more direct, stating the goal is to make Johnson effectively immortal by 2039.
Johnson frames the livestream as a democratic distribution of his protocol, offering the findings to the public for free. He positions psilocybin as a critical component in identifying therapies that can slow the speed of aging and repair cellular damage accumulated over time.
Biometrics Over Bliss: The New Longevity Lab
The setting of the livestream reinforced the shift from psychedelic exploration to clinical biohacking. Instead of the vibrant, artistic backdrops of the 1960s, Johnson occupied a sterile, beige room filled with laptops and monitoring equipment. The corporate atmosphere was so pronounced that Marc Benioff joked about the missed opportunity for a sleep mask sponsorship.
The session concluded with a series of rigorous data collection steps. Tolo gathered saliva samples from Johnson before placing a high-tech black helmet on his head. This device recorded neurological activity while Johnson remained stationary, staring at a wall. This data-driven spectacle represents the new frontier of the longevity movement, where the pursuit of immortality is quantified through biometrics and shared in real-time with the world’s most powerful tech influencers.
